Calls Now Open
2022 ADDF-Harrington and 2023 Harrington UK Rare Disease Programs
Oncology
Novel Ligand-Based CAR-NK Cell Therapy for the Treatment of B Cell Malignancies
2021 Harrington CWRU-MSTP Scholar
Full profile coming soon.